No connection

Search Results

CUBI

NEUTRAL
$74.38 Live
Customers Bancorp, Inc. · NYSE
Target $88.73 (+19.3%)
$48.63 52W Range $82.56

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 26, 2026
Market cap
$2.51B
P/E
9.37
ROE
14.0%
Profit margin
34.8%
Debt/Equity
N/A
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
80%
CUBI presents a stark contradiction between explosive growth and deteriorating fundamental health. While the Piotroski F-Score of 2/9 indicates significant weakness in financial health, the stock is fundamentally undervalued, trading well below its Graham Number ($105.14) and Intrinsic Value ($234.23). Massive YoY earnings growth (579.30%) and a low P/E of 9.37 provide a strong value proposition, but the bearish technical trend (10/100) and poor health score suggest high risk. The overall outlook is neutral until the underlying health metrics stabilize.

Key Strengths

Exceptional YoY earnings growth of 579.30%
Strong revenue growth (76.40% YoY)
Attractive valuation with a P/E of 9.37 and Forward P/E of 7.94
Trading at a significant discount to Graham Number ($105.14)
Consistent track record of beating earnings estimates (3/4 last quarters)

Key Risks

Critical financial health warning indicated by Piotroski F-Score of 2/9
Strongly bearish technical trend (10/100)
Lack of dividend income and low dividend strength (0/100)
Low insider sentiment (40/100) with no recent buy activity
Regional bank sector volatility and sensitivity to interest rate shifts
AI Fair Value Estimate
Based on comprehensive analysis
$98.5
+32.4% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
54
Moderate
Value
90
Future
85
Past
75
Health
20
Dividend
0
AI Verdict
High-Risk Value Play
Key drivers: Extreme earnings growth, Deep valuation discount, Poor fundamental health score
Confidence
85%
Value
90/100

Ref P/E 9.37, PEG 1.18, Graham Number $105.14

Positives
  • P/E well below sector average
  • Price < Graham Number
  • Low Price/Book (1.20)
Watchpoints
  • Market pricing in health risks
Future
85/100

Ref 579.30% Earnings Growth

Positives
  • Massive YoY revenue and earnings acceleration
  • Positive analyst target price ($88.73)
Watchpoints
  • Recent Q/Q EPS growth dip (-4.4%)
Past
75/100

Ref 3Y Change +321.4%

Positives
  • Strong 3Y and 5Y price appreciation
  • Consistent earnings beat history
Watchpoints
  • Recent short-term technical decline
Health
20/100

Ref Piotroski F-Score 2/9

Positives
  • Positive ROE (14.01%)
Watchpoints
  • Piotroski F-Score of 2/9 is critically weak
  • Lack of available Altman Z-Score for bankruptcy risk assessment
Dividend
0/100

Ref Dividend Strength 0/100

Positives
No standout positives identified.
Watchpoints
  • No dividend yield
  • 0% payout ratio

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$74.38
Analyst Target
$88.73
Upside/Downside
+19.3%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for CUBI and closest competitors.

Updated 2026-04-24
CUB
Customers Bancorp, Inc.
Primary
5Y
+130.3%
3Y
+321.4%
1Y
+47.8%
6M
+6.1%
1M
+7.2%
1W
-3.9%
BBU
Brookfield Business Corporation
Peer
5Y
+0.1%
3Y
+62.8%
1Y
+52.8%
6M
+10.6%
1M
-3.1%
1W
-2.6%
FRM
First Merchants Corporation
Peer
5Y
+7.1%
3Y
+50.5%
1Y
+20.0%
6M
+11.4%
1M
+6.6%
1W
-1.2%
TBB
The Bancorp, Inc.
Peer
5Y
+162.3%
3Y
+122.0%
1Y
+16.5%
6M
-26.4%
1M
+10.3%
1W
-6.1%
SLD
Slide Insurance Holdings, Inc.
Peer
5Y
-3.1%
3Y
-3.1%
1Y
-3.1%
6M
+33.7%
1M
+10.6%
1W
+9.1%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
9.37
Forward P/E
7.94
PEG Ratio
1.18
P/B Ratio
1.2
P/S Ratio
3.1
EV/Revenue
-0.48
EV/EBITDA
N/A
Market Cap
$2.51B

Profitability

Profit margins and return metrics

Profit Margin 34.76%
Operating Margin 48.7%
Gross Margin N/A
ROE 14.01%
ROA 1.16%

Growth

Revenue and earnings growth rates

Revenue Growth +76.4%
Earnings Growth +579.3%
Q/Q Revenue Growth +53.81%
Q/Q Earnings Growth +439.4%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$142.41

Quarterly Earnings History

EPS performance vs analyst estimates

2026-07-23
$N/A
2026-04-23
$1.97
+4.4% surprise
2026-01-22
$2.06
+0.8% surprise
2025-10-23
$2.2
+14.0% surprise

Financial Services Sector Comparison

Comparing CUBI against 693 companies in the Financial Services sector (118 bullish, 285 neutral, 290 bearish)
P/E Ratio
9.37
This Stock
vs
38.68
Sector Avg
-75.8% (Discount)
Return on Equity (ROE)
14.01%
This Stock
vs
-2.84%
Sector Avg
-592.5% (Below Avg)
Profit Margin
34.76%
This Stock
vs
59.37%
Sector Avg
-41.5% (Weaker)
Revenue Growth
76.4%
This Stock
vs
40.21%
Sector Avg
+90.0% (Fast Growth)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

SIDHU SAMVIR S
Chief Executive Officer
Stock Award
2026-04-06
37,136 shares · $2,662,651
SIDHU JAY S
Chairman of the Board
Stock Award
2026-04-06
51,626 shares · $3,701,584
ZUCKERMAN STEVEN J
Director
Stock Award
2026-03-16
953 shares · $61,678
ALLON ANDREA R.
Director
Stock Award
2026-03-16
625 shares · $40,450
GILL MIKE
Director
Stock Award
2026-03-16
625 shares · $40,450
BUFORD ROBERT J
Director
Stock Award
2026-03-16
895 shares · $57,924
WAY T LAWRENCE
Director
Stock Award
2026-03-16
895 shares · $57,924
MACKAY ROBERT NEIL
Director
Stock Award
2026-03-16
895 shares · $57,924
KRASNE ROBERT MORRIS
Director
Stock Award
2026-03-16
895 shares · $57,924
LOONEY SUSAN DIANE
Director
Stock Award
2026-03-16
625 shares · $40,450
SIRMANS DALTON TALLEY
Director
Stock Award
2026-03-16
760 shares · $49,187
BANKS BERNARD BENNETT
Director
Stock Award
2026-03-16
934 shares · $60,448
ROTHERMEL DANIEL K
Director
Stock Award
2026-03-16
625 shares · $40,450
VELASQUEZ JESSIE JOHN DEANO
Officer
Stock Award
2026-03-13
1,206 shares · $78,052
SIDHU JAY S
Chairman of the Board
Gift
2025-12-31
1,552 shares · $113,917
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
11 analysts
JP Morgan
2026-04-01
Maintains
Overweight Overweight
Morgan Stanley
2026-03-31
Maintains
Equal-Weight Equal-Weight
Stephens & Co.
2026-03-16
up
Underweight Equal-Weight
JP Morgan
2026-03-06
init
Overweight
Morgan Stanley
2026-03-02
Maintains
Equal-Weight Equal-Weight
DA Davidson
2026-01-26
Maintains
Buy Buy
Morgan Stanley
2025-12-08
init
Equal-Weight
Stephens & Co.
2025-10-28
Maintains
Equal-Weight Equal-Weight

Past News Coverage

Recent headlines mentioning CUBI from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile